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CDG nomenclature: time for a change! 
 
Jaeken J, Hennet T, Matthijs G, Freeze H  
 
 
Congenital disorders of glycosylation (CDG) are a rapidly growing disease family with nearly 
40 diseases reported since its first clinical description in 1980 (1).  The large majority of these 
are protein hypoglycosylation diseases, but in recent years several defects in lipid 
glycosylation have been identified (2,3). Most protein glycosylation disorders are due to 
defects in the N-glycosylation pathway, the remaining ones affecting the O-glycosylation 
disorders or combined N- and O-glycosylation pathways. No defects in C-glycosylation have 
been detected yet. The first described CDG patients were shown to have an abnormal serum 
transferrin (Tf) isoelectrofocusing (IEF) pattern with increases in the di- and asialotransferrin 
fractions (4 ). They were found to have deficient phosphomannomutase (PMM) activity (5) 
and mutations in the PMM2 gene (6). PMM deficient patients were designated as CDG-Ia. 
Subsequently, a patient was discovered with a serum Tf IEF pattern characterized by 
increases not only of the even (2 and 0) but also of the uneven (3 and 1) sialoTf bands (7). 
Since these patterns were qualitatively different, we called the latter a type 2 pattern as 
opposed to the type 1 pattern seen in PMM deficiency. In the patient with the type 2 pattern, a 
deficiency was demonstrated to be in a Golgi glycosyltransferase, namely N-
acetylglucosaminyltransferase II (8). This disease was labelled CDG-IIa. New patients were 
classified as CDG-I or CDG-II depending on the Tf IEF pattern, and each new defect took the 
next letter of the alphabet.  
We presently count 14 CDG-I diseases (CDG-Ia up to CDG-In), and 8 CDG-II diseases 
(CDG-IIa up to CDG-IIh). Since this nomenclature is based on the Tf IEF pattern, it relates 
only to N-glycosylation diseases associated with deficient sialylation. Gradually it became 
clear that CDG-I defects were limited to defects in pre-ER or ER proteins whereas CDG-II 
defects were caused by defects in Golgi or Golgi-associated proteins. However, some of these 
disorders also show abnormal O-glycosylation e.g. COG defects (review in 9) and the V-
ATPase defect in cutis laxa type II (10). Also, it appeared that a patient with an alpha-
glucosidase-II deficiency in the ER had a normal Tf IEF pattern (11). Still this patient was 
labeled as CDG-IIb, which is an inconsistency of this classification. For this reason and for a 
number of other reasons explained elsewhere (12 ), we strongly suggest that this 
nomenclature be discontinued in favour of a new one and that it be applied to new and 
established types of CDG. We propose using only the gene name, with the option of adding 
CDG in parentheses after the gene name. An updated list of the known types of CDG, along 
with the traditional and new classification, is shown in the Table (12). 
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